vs
ICAHN ENTERPRISES L.P.(IEP)与瑞思迈(RMD)财务数据对比。点击上方公司名可切换其他公司
ICAHN ENTERPRISES L.P.的季度营收约是瑞思迈的1.9倍($2.7B vs $1.4B),瑞思迈净利率更高(27.6% vs 0.0%,领先27.6%),瑞思迈同比增速更快(11.0% vs 5.4%),瑞思迈自由现金流更多($311.2M vs $-496.0M),过去两年瑞思迈的营收复合增速更高(9.0% vs 4.5%)
伊坎企业有限合伙企业是美国上市的 Master 有限合伙企业与多元化集团,总部位于佛罗里达州阳光岛海滩的弥尔顿大厦。公司投资布局覆盖能源、汽车、食品包装、金属、房地产、家居时尚等多个领域,由知名投资人卡尔·伊坎控股,其持股比例达86%。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业,主打可接入云端的呼吸类医疗设备,用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病,新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
IEP vs RMD — 直观对比
营收规模更大
IEP
是对方的1.9倍
$1.4B
营收增速更快
RMD
高出5.6%
5.4%
净利率更高
RMD
高出27.6%
0.0%
自由现金流更多
RMD
多$807.2M
$-496.0M
两年增速更快
RMD
近两年复合增速
4.5%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $2.7B | $1.4B |
| 净利润 | $1.0M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 0.6% | 34.6% |
| 净利率 | 0.0% | 27.6% |
| 营收同比 | 5.4% | 11.0% |
| 净利润同比 | 101.0% | 13.9% |
| 每股收益(稀释后) | — | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IEP
RMD
| Q4 25 | $2.7B | $1.4B | ||
| Q3 25 | $2.7B | $1.3B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $2.6B | $1.3B | ||
| Q3 24 | $2.8B | $1.2B | ||
| Q2 24 | $2.2B | $1.2B | ||
| Q1 24 | $2.5B | $1.2B |
净利润
IEP
RMD
| Q4 25 | $1.0M | $392.6M | ||
| Q3 25 | $287.0M | $348.5M | ||
| Q2 25 | $-165.0M | $379.7M | ||
| Q1 25 | $-422.0M | $365.0M | ||
| Q4 24 | $-98.0M | $344.6M | ||
| Q3 24 | $22.0M | $311.4M | ||
| Q2 24 | $-331.0M | $292.2M | ||
| Q1 24 | $-38.0M | $300.5M |
毛利率
IEP
RMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率
IEP
RMD
| Q4 25 | 0.6% | 34.6% | ||
| Q3 25 | 19.7% | 33.4% | ||
| Q2 25 | -10.4% | 33.7% | ||
| Q1 25 | -35.0% | 33.0% | ||
| Q4 24 | -5.2% | 32.5% | ||
| Q3 24 | 2.4% | 31.6% | ||
| Q2 24 | -21.9% | 31.2% | ||
| Q1 24 | -0.8% | 31.3% |
净利率
IEP
RMD
| Q4 25 | 0.0% | 27.6% | ||
| Q3 25 | 10.5% | 26.1% | ||
| Q2 25 | -7.0% | 28.2% | ||
| Q1 25 | -22.6% | 28.3% | ||
| Q4 24 | -3.8% | 26.9% | ||
| Q3 24 | 0.8% | 25.4% | ||
| Q2 24 | -15.0% | 23.9% | ||
| Q1 24 | -1.5% | 25.1% |
每股收益(稀释后)
IEP
RMD
| Q4 25 | — | $2.68 | ||
| Q3 25 | — | $2.37 | ||
| Q2 25 | — | $2.58 | ||
| Q1 25 | — | $2.48 | ||
| Q4 24 | — | $2.34 | ||
| Q3 24 | — | $2.11 | ||
| Q2 24 | — | $1.97 | ||
| Q1 24 | — | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | — | $6.3B |
| 总资产 | $14.2B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势,按日历期对齐
现金及短期投资
IEP
RMD
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.8B | $1.4B | ||
| Q2 25 | $1.8B | $1.2B | ||
| Q1 25 | $2.2B | $932.7M | ||
| Q4 24 | $2.6B | $521.9M | ||
| Q3 24 | $2.3B | $426.4M | ||
| Q2 24 | $2.2B | $238.4M | ||
| Q1 24 | $2.5B | $237.9M |
总债务
IEP
RMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益
IEP
RMD
| Q4 25 | — | $6.3B | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | — | $6.0B | ||
| Q1 25 | — | $5.5B | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | $5.2B | ||
| Q2 24 | — | $4.9B | ||
| Q1 24 | — | $4.6B |
总资产
IEP
RMD
| Q4 25 | $14.2B | $8.5B | ||
| Q3 25 | $14.8B | $8.3B | ||
| Q2 25 | $14.8B | $8.2B | ||
| Q1 25 | $15.5B | $7.6B | ||
| Q4 24 | $16.3B | $7.1B | ||
| Q3 24 | $17.4B | $7.2B | ||
| Q2 24 | $18.0B | $6.9B | ||
| Q1 24 | $20.1B | $6.8B |
负债/权益比
IEP
RMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-421.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $-496.0M | $311.2M |
| 自由现金流率自由现金流/营收 | -18.4% | 21.9% |
| 资本支出强度资本支出/营收 | 2.8% | 2.0% |
| 现金转化率经营现金流/净利润 | -421.00× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $-654.0M | $1.8B |
8季度趋势,按日历期对齐
经营现金流
IEP
RMD
| Q4 25 | $-421.0M | $339.7M | ||
| Q3 25 | $15.0M | $457.3M | ||
| Q2 25 | $275.0M | $538.8M | ||
| Q1 25 | $-182.0M | $578.7M | ||
| Q4 24 | $244.0M | $308.6M | ||
| Q3 24 | $-54.0M | $325.5M | ||
| Q2 24 | $893.0M | $440.1M | ||
| Q1 24 | $-251.0M | $402.0M |
自由现金流
IEP
RMD
| Q4 25 | $-496.0M | $311.2M | ||
| Q3 25 | $-67.0M | $414.4M | ||
| Q2 25 | $179.0M | $508.2M | ||
| Q1 25 | $-270.0M | $557.9M | ||
| Q4 24 | $156.0M | $288.0M | ||
| Q3 24 | $-112.0M | $307.7M | ||
| Q2 24 | $827.0M | $415.2M | ||
| Q1 24 | $-319.0M | $380.8M |
自由现金流率
IEP
RMD
| Q4 25 | -18.4% | 21.9% | ||
| Q3 25 | -2.5% | 31.0% | ||
| Q2 25 | 7.6% | 37.7% | ||
| Q1 25 | -14.5% | 43.2% | ||
| Q4 24 | 6.1% | 22.5% | ||
| Q3 24 | -4.0% | 25.1% | ||
| Q2 24 | 37.6% | 33.9% | ||
| Q1 24 | -12.9% | 31.8% |
资本支出强度
IEP
RMD
| Q4 25 | 2.8% | 2.0% | ||
| Q3 25 | 3.0% | 3.2% | ||
| Q2 25 | 4.1% | 2.3% | ||
| Q1 25 | 4.7% | 1.6% | ||
| Q4 24 | 3.4% | 1.6% | ||
| Q3 24 | 2.1% | 1.5% | ||
| Q2 24 | 3.0% | 2.0% | ||
| Q1 24 | 2.8% | 1.8% |
现金转化率
IEP
RMD
| Q4 25 | -421.00× | 0.87× | ||
| Q3 25 | 0.05× | 1.31× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | -2.45× | 1.05× | ||
| Q2 24 | — | 1.51× | ||
| Q1 24 | — | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IEP
| Public Utilities Inventory Petroleum Products | $1.6B | 61% |
| Other | $381.0M | 14% |
| Automotive Services | $345.0M | 13% |
| Nitrogen Fertilizer Products | $131.0M | 5% |
| Food Packaging Segment | $82.0M | 3% |
| Home Fashion Segment | $45.0M | 2% |
| Renewable Products | $32.0M | 1% |
| Pharma Segment | $23.0M | 1% |
| Holding Company | $11.0M | 0% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |